News from Decision Resources, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Sep 23, 2014, 13:00 ET The U.S. Surgical Navigation System Market Will Expand to $260 Million By 2023

Decision Resources Group finds that the United States market for surgical navigation systems will gradually expand due to demand for minimally...


Jun 02, 2014, 10:00 ET Surveyed Hematologists in China Expect the Market Entry of Generic Imatinib to Significantly Decrease Glivec's Patient Share in Chronic Myeloid Leukemia

 Decision Resources Group finds that surveyed hematologists in China estimate that Novartis's Glivec (imatinib) will lose nearly half of its...


May 19, 2014, 10:00 ET While Gilead's Sovaldi Continues to Dominate the Hepatitis C Space, Janssen's Olysio Has Gained Market Share Driven by Off-label Prescribing

 Decision Resources Group finds that, for the treatment of hepatitis C virus (HCV) infections, regimens containing Gilead's Sovaldi account for...


Apr 17, 2014, 11:30 ET Surveyed U.S. Physicians Expect Strong Uptake of Novel Oral Anticoagulants for the Treatment of VTE

 Decision Resources Group finds that the novel oral anticoagulants (NOACs) will dramatically alter the treatment landscape for VTE treatment...


Apr 14, 2014, 10:32 ET U.S. Market for Nonbreast Aesthetic Implants Will Decline Due to Widespread Preference for Alternative Treatments

 Decision Resources Group finds that the United States market for nonbreast aesthetic implants will decline as alternative treatments such as...


Feb 18, 2014, 13:00 ET Medicaid Expansion, Medicare Reimbursement And The Next Level Of Healthcare Information Technology: U.S. Managed Markets Continue Titanic Shifts In 2014

Decision Resources Group's team of subject matter experts have analyzed the market forces affecting U.S. Healthcare in 2014, and outlined...


Feb 18, 2014, 10:00 ET European Market For Varicose Vein Treatment Devices Will Reach $65 Million by 2022

  Decision Resources Group finds that adoption of treatments for varicose veins in Europe will increase overall but will vary significantly by...


Jan 28, 2014, 10:00 ET Global Market for Hyaluronic Acid Viscosupplementation to Reach $2.8 Billion by 2022

According to Decision Resources Group, the market for hyaluronic acid (HA) viscosupplementation treatments will expand globally through 2022....


Dec 23, 2013, 09:00 ET Taiwan Spends a High Percentage of its Healthcare Budget on Pharmaceuticals, but Second Generation Healthcare Reform is Transforming the Market Landscape

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the high level of...


Dec 23, 2013, 09:00 ET Brazil's National Health System Currently Provides Coverage for 22 Drugs that are Distributed Free of Charge to Over 300,000 HIV-Infected Patients

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Brazil's National...


Dec 19, 2013, 13:00 ET Immunotherapies Will Continue to Dominate the Malignant Melanoma Drug Market with Sales of Immune Checkpoint Inhibitors Accounting for Majority of Sales in this Drug Class in 2022

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the...


Dec 19, 2013, 12:00 ET The Atherothrombotic Diseases Market Will Increase from $36 Billion in 2012 to $47 Billion in 2022

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch of...


Dec 19, 2013, 11:00 ET The Novel Oral Anticoagulants Will Continue to Drive Growth in the Atrial Fibrillation Drug Market

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the atrial...


Dec 19, 2013, 08:00 ET The Prostate Cancer Drug Market Will Experience Approximately 10 Percent Annual Growth from 2012 to 2022, Reaching $8.6 Billion in the Major Markets in 2022

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the prostate cancer...


Dec 19, 2013, 08:00 ET New Biologics Must Show Improvements in Efficacy, Safety and Cost-Benefit Compared with Currently Available Agents for Inclusion on Formularies in Argentina, Brazil and Mexico

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that novel...


Dec 18, 2013, 10:00 ET Decision Resources to Publish Reports That Include Market Analysis and a Forecast through 2022 for the Hepatitis C Virus and Hospital-Treated Bacterial Infections Drug Markets

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, will soon publish a...


Dec 18, 2013, 08:00 ET The Asthma Drug Market Will Remain Relatively Flat, Increasing Slightly from $15.3 Billion in 2012 to $16.2 Billion in 2022

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the drug...


Dec 18, 2013, 08:00 ET Biosimilars for Rheumatoid Arthritis Will Experience Rapid Uptake in the Public Sectors of Brazil and Mexico, Which Have Powerful Mechanisms that Drive Use of Lower Cost Options

BURLINGTON, Mass., Dec. 18, 2013 /PRNewswire/-- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and...


Dec 17, 2013, 13:00 ET Thailand's Population Has Universal Access to Health Services and Generous Reimbursement for Essential Medicines, Making it a Market of High Interest in Southeast Asia

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that...


Dec 17, 2013, 10:00 ET Decision Resources to Publish Reports Assessing Unmet Need and Commercial Opportunities in the Cardiovascular and Metabolic Diseases Drug Markets

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, will soon publish analysis of...


Dec 17, 2013, 09:28 ET Forty Blockbuster Drug Brands Will Lose Patent Exclusivity Between 2013 and 2020

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that between 2013...


Dec 16, 2013, 10:00 ET The Epilepsy Market Will Grow 2 Percent Annually Through 2022 with Expanding Uptake of Third-Generation Brands

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the market...


Dec 16, 2013, 10:00 ET Unmet Need in Rare Cancers Remains High

   Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that...


Dec 16, 2013, 09:00 ET U.S. Gastroenterologists Have Increased Their Use Of TNF-alpha Inhibitors For The Treatment Of Crohn's Disease Compared To Last Year

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that through an...


Dec 16, 2013, 08:00 ET When Prescribing New Drugs for Crohn's Disease or Ulcerative Colitis, Surveyed EU5 Gastroenterologists Will Prioritize Remission Rates Over Cost and Reimbursement Hurdles

 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, when...